These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3083783)

  • 1. [Factors controlling tumor promotion induced by TPA].
    Kato R; Yamamoto S; Nakadate T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):782-9. PubMed ID: 3083783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
    Nakadate T; Yamamoto S; Ishii M; Kato R
    Cancer Res; 1982 Jul; 42(7):2841-5. PubMed ID: 6805948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK; Pong RC; Erickson D
    Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Gan; 1984 Mar; 75(3):214-22. PubMed ID: 6427052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lipoxygenase and cyclooxygenase inhibitors on the induction of ornithine decarboxylase by 12-O-tetradecanoylphorbol-13-acetate and isoproterenol in mouse tissues in vivo.
    Uzumaki H; Yamamoto S; Kato R
    Carcinogenesis; 1986 Feb; 7(2):289-94. PubMed ID: 3081271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition.
    Kato R; Nakadate T; Yamamoto S; Sugimura T
    Carcinogenesis; 1983 Oct; 4(10):1301-5. PubMed ID: 6413085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-mediated epidermal ornithine decarboxylase induction and skin tumor promotion by new lipoxygenase inhibitors lacking protein kinase C inhibitory effects.
    Aizu E; Nakadate T; Yamamoto S; Kato R
    Carcinogenesis; 1986 Nov; 7(11):1809-12. PubMed ID: 3094975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and tumor promotion by N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) in mouse skin.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Pharmacology; 1986; 32(3):167-75. PubMed ID: 3083437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
    Verma AK
    Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and epidermal ornithine decarboxylase activity in mouse skin by palmitoylcarnitine.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Cancer Res; 1986 Apr; 46(4 Pt 1):1589-93. PubMed ID: 3081251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potent anti-tumor-promoting agent isoliquiritigenin.
    Yamamoto S; Aizu E; Jiang H; Nakadate T; Kiyoto I; Wang JC; Kato R
    Carcinogenesis; 1991 Feb; 12(2):317-23. PubMed ID: 1899810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion by nordihydroguaiaretic acid, a lipoxygenase inhibitor, and p-bromophenacyl bromide, a phospholipase A2 inhibitor.
    Nakadate T; Yamamoto S; Iseki H; Sonoda S; Takemura S; Ura A; Hosoda Y; Kato R
    Gan; 1982 Dec; 73(6):841-3. PubMed ID: 6819174
    [No Abstract]   [Full Text] [Related]  

  • 13. Palmitoylcarnitine reverses 12-O-tetradecanoylphorbol-13-acetate-induced refractory state for the TPA-caused ornithine decarboxylase induction in mouse epidermis.
    Aizu E; Yamamoto S; Nakadate T; Kiyoto I; Kato R
    Carcinogenesis; 1988 Feb; 9(2):309-13. PubMed ID: 3338115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
    Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R
    Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C.
    Fischer SM; Jasheway DW; Klann RC; Butler AP; Patrick KE; Baldwin JK; Cameron GS
    Cancer Res; 1989 Dec; 49(23):6693-9. PubMed ID: 2819717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism.
    Fischer SM; Mills GD; Slaga TJ
    Carcinogenesis; 1982; 3(11):1243-5. PubMed ID: 7151243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
    Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Weekes RG; Verma AK; Boutwell RK
    Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
    Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
    Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of skin tumor promotion by retinoic acid and its metabolite 5,6-epoxyretinoic acid.
    Verma AK; Slaga TJ; Wertz PW; Mueller GC; Boutwell RK
    Cancer Res; 1980 Jul; 40(7):2367-71. PubMed ID: 7388798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.